Supply of raw materials has been a risk to the biomanufacturing industry for many years, however, the pandemic has worsened and accelerated what is now no longer a risk but a reality.
The session will explore how industry and the regulators are mitigating risks for the current and future state of the raw material supply chain; three perspectives will be shared, that of suppliers, end users and regulators.
Session Speakers: 10:45 - 11:10 Managing Raw Material Supply Chain Challenges during the COVID-19 Pandemic and Resulting Future Opportunities - A Roche Perspective V Stefan Paschen, Roche Diagnostics GmbH
11:10 - 11:35 Supplying an mRNA COVID 19 Vaccine at Unprecedented Pace and Scale V David Sullivan, Pfizer, Inc.
11:35 - 12:00 Regulatory Approaches to Manage Supply Chain Challenges V Patricia Hughes, CDER, FDA